The medical course of CLL is quite heterogeneous, starting from a fairly asymptomatic ailment that may even regress spontaneously to the progressive condition that inevitably contributes to the affected individual’s Loss of life, so there has normally been impressive desire in identifying the prognosis of unique individuals. Regardless that numer